Bird & Bird advised Fonds Patient Autonome and Uniqa Ventures on their €4 million financing round of Fizimed

International law firm Bird & Bird advised Fonds Patient Autonome, managed by Bpifrance, and Uniqa Ventures on their participation in the €4 million financing round of Fizimed, a femtech dedicated to women's health.

The Fonds Patient Autonome and Uniqa Ventures led the financing round, in which UI Investissement also participated.

The Bird & Bird team advising Fonds Patient Autonome and Uniqa Ventures comprised of partner Carole Bodin and associate Pascaline Sagot, who advised on the corporate aspects, with partner Alexandre Vuchot and associate Caroline Arrighi-Savoie advising on the regulatory aspects.

The company was advised by Charles Russell Speechlys. The team comprised of partner Renaud Ferry and Counsel Orlando Vignoli Neto.

News & Deals

More News & Deals

News

Bird & Bird secures important judgment for Destin Trading Inc in The High Court

Mar 28 2025

Read More

News

Bird & Bird secures important victory for wealth manager XY against ex-Ferrari Chairman

Mar 28 2025

Read More

Deal

Bird & Bird advises Move Repeat on Strategic Investment in REVL Holdings

Mar 28 2025

Read More

News

Bird & Bird boosts Corporate team with new partner Henrik Nobel in Stockholm

Mar 17 2025

Read More

Deal

Bird & Bird advises Nrep on the acquisition of a significant care home portfolio

Mar 12 2025

Read More

Deal

Bird & Bird advises HomeServe on the continuous growth of the German HVAC group

Mar 11 2025

Read More